Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SuperMeat develops cultivated chicken by growing muscle and fat tissue directly from embryonic avian stem cells using scalable bioreactor processes. The company has achieved high cell densities (~80 million cells/mL in nine days) without genetic modification or animal-derived components. Its technology enables rapid muscle growth in four days and fat in just one day. SuperMeat’s recent advances have brought the cost of its product close to price parity with premium conventional poultry ($11.79/lb at scale), positioning it as one of the most advanced companies globally in terms of scalability, efficiency, and sustainability for cultivated chicken production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SuperMeat.